As BIO 2025 approaches in Boston, eight pivotal trends are emerging at the intersection of science, business, IP, and regulation:

1. AI‑Driven Breakthroughs 
2. Gene‑Editing Revolution 
3. Precision & Metabolomics Medicine 
4. Innovation in Clinical Trials 
5. Immunology & Inflammation Focus 
6. Scaling M&A & Financing 
7. Sustainable Biomanufacturing 
8. Regulatory & IP Readiness 

From AI and gene therapies to sustainable bio-manufacturing and inclusive trials, the next chapter of biotech is being written now. We’re looking forward to all the great discussions we’ll be having next week!

Want to dive deeper? Read our full article, “What We’re Watching Ahead of BIO 2025: Shaping the Future of Biotech” to explore how these trends intersect with financing, IP, risk management, and litigation ahead of the event.